Lynparza 100 mg film-coated tablets, AZD2281, AZD2281, AZD2281
D0816C00025
Phase 1 small_molecule active
Quick answer
Lynparza 100 mg film-coated tablets, AZD2281, AZD2281, AZD2281 for solid tumors is a Phase 1 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- solid tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active